Regeneron's Dupixent leads growth as Eylea sales decline and valuation is attractive, but growth is delayed by 2-3 years.

Here's a look at the analyst estimates, what experts are saying and key items to watch. Earnings Estimates: Analysts expect Nike to report fourth-quarter revenue of $10.71 billion, down from $12.61 ...

Wednesday closed down -6.85 (-2.20%), and September ICE robusta coffee (RMU25 ) closed down -158 (-4.29%). Coffee prices on ...

September arabica coffee (KCU25 ) today is down -7.20 (-2.31%), and July ICE robusta coffee (RMN25 ) is down -197 (-5.15%).

Before Wall Street even had its morning coffee on Monday, June 23, Estée Lauder (EL) stole the spotlight. There was no press ...

More than half of Alabama's mortgage rates are under 4%. Data: Cotality Mortgage Analysis; Map: Jacque Schrag/Axios One bright spot in this bummer housing market: More listings are shaking loose. Why ...

(Reuters) -U.S. total new vehicle sales are expected to rise 2.5% to 1.25 million units on an adjusted basis for the month of ...

Eutelsat is pivotal for Europe's digital sovereignty. We see triple digit upside for the stock. See here for a detailed ...

Paychex reported lower-than-expected sales, with most of its increase coming from the purchase of human capital management ...

The price of Polygon (MATIC) is projected to steadily rise from 2025 to 2031, according to the forecast data. In 2025, the ...